Mylan (MYL) Upgraded by BidaskClub to Hold

BidaskClub upgraded shares of Mylan (NASDAQ:MYL) from a sell rating to a hold rating in a research report report published on Wednesday.

MYL has been the subject of a number of other research reports. ValuEngine downgraded shares of Mylan from a hold rating to a sell rating in a research report on Wednesday, May 2nd. Zacks Investment Research raised shares of Mylan from a sell rating to a hold rating in a research report on Tuesday, January 16th. Susquehanna Bancshares reaffirmed a positive rating and issued a $55.00 target price (up previously from $47.00) on shares of Mylan in a research report on Thursday, January 25th. Morgan Stanley set a $50.00 target price on shares of Mylan and gave the stock a buy rating in a research report on Monday, April 9th. Finally, Cantor Fitzgerald set a $41.00 price objective on shares of Mylan and gave the company a hold rating in a research report on Thursday, March 1st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and fourteen have assigned a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $47.02.

NASDAQ:MYL opened at $39.18 on Wednesday. The company has a quick ratio of 0.65, a current ratio of 1.06 and a debt-to-equity ratio of 1.03. Mylan has a 12 month low of $38.30 and a 12 month high of $39.07. The company has a market capitalization of $19.84 billion, a price-to-earnings ratio of 8.59, a P/E/G ratio of 1.25 and a beta of 1.35.

Mylan (NASDAQ:MYL) last posted its earnings results on Wednesday, May 9th. The company reported $0.96 EPS for the quarter, missing analysts’ consensus estimates of $0.99 by ($0.03). Mylan had a return on equity of 18.56% and a net margin of 6.04%. The company had revenue of $2.68 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same period last year, the firm posted $0.93 EPS. The company’s revenue for the quarter was down 1.3% on a year-over-year basis. sell-side analysts forecast that Mylan will post 5.36 earnings per share for the current year.

In related news, Director Robert J. Coury sold 150,000 shares of the company’s stock in a transaction on Friday, March 2nd. The shares were sold at an average price of $40.10, for a total value of $6,015,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Anthony Mauro sold 12,257 shares of the company’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $40.35, for a total transaction of $494,569.95. Following the completion of the transaction, the insider now directly owns 147,435 shares of the company’s stock, valued at approximately $5,949,002.25. The disclosure for this sale can be found here. Insiders sold a total of 269,287 shares of company stock valued at $11,034,960 in the last ninety days. 0.69% of the stock is currently owned by insiders.

A number of institutional investors have recently modified their holdings of MYL. Lingohr & Partner Asset Management GmbH lifted its stake in Mylan by 5.0% in the 4th quarter. Lingohr & Partner Asset Management GmbH now owns 22,979 shares of the company’s stock worth $972,000 after purchasing an additional 1,100 shares in the last quarter. HM Payson & Co. lifted its stake in Mylan by 7.3% in the 4th quarter. HM Payson & Co. now owns 21,938 shares of the company’s stock worth $928,000 after purchasing an additional 1,498 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in Mylan by 23.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 8,283 shares of the company’s stock worth $349,000 after purchasing an additional 1,596 shares in the last quarter. Natixis Advisors L.P. lifted its stake in Mylan by 2.6% in the 1st quarter. Natixis Advisors L.P. now owns 70,253 shares of the company’s stock worth $2,892,000 after purchasing an additional 1,781 shares in the last quarter. Finally, Ladenburg Thalmann Financial Services Inc. lifted its stake in Mylan by 25.4% in the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 9,080 shares of the company’s stock worth $384,000 after purchasing an additional 1,840 shares in the last quarter. 83.53% of the stock is owned by institutional investors.

Mylan Company Profile

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Analyst Recommendations for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Empire Resorts  Upgraded by BidaskClub to Hold
Empire Resorts Upgraded by BidaskClub to Hold
Qiwi  Downgraded to “Hold” at BidaskClub
Qiwi Downgraded to “Hold” at BidaskClub
Mylan  Upgraded by BidaskClub to Hold
Mylan Upgraded by BidaskClub to Hold
iKang Healthcare Group  Lowered to Hold at BidaskClub
iKang Healthcare Group Lowered to Hold at BidaskClub
Reviewing II-VI  & KLA-Tencor
Reviewing II-VI & KLA-Tencor
Head-To-Head Analysis: Neogen  & Quidel
Head-To-Head Analysis: Neogen & Quidel


Leave a Reply

© 2006-2018 Ticker Report. Google+.